Mary R Cahill
Overview
Explore the profile of Mary R Cahill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
317
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kont A, Mendonca M, Malanga M, Felegyi K, Lindsay A, Cronin M, et al.
Int J Pharm
. 2024 Dec;
670:125107.
PMID: 39708848
The presence of multiple hydroxyl groups at positions C2, C3 and C6 on the cyclodextrin (CD) ring structure allows for extensive functionalisation, enabling the development of biomaterials with significant potential...
2.
Millar S, Mohamed M, Mykytiv V, McMorrow R, Donnelly C, OLeary E, et al.
Ir J Med Sci
. 2024 Jul;
193(6):2615-2623.
PMID: 39030463
Background: The Blood Cancer Network Ireland and National Cancer Registry Ireland worked to create an Enhanced Blood Cancer Outcomes Registry (EBCOR). Enhanced data in acute myeloid leukaemia (AML) included an...
3.
Cronin T, Ronayne C, ODonovan N, McGuinness E, Cooke K, Dennehy M, et al.
Ir J Med Sci
. 2024 May;
193(5):2171-2177.
PMID: 38806877
Background: Expanded access programs (EAPs) allow cancer patients with unmet clinical need to obtain access to pre-authorisation treatments. There is no standardised process for implementing these programs nationally, and real-world...
4.
Keogh R, Harvey H, Brady C, Hassett E, Costelloe S, OSullivan M, et al.
J Cancer Policy
. 2024 Jan;
39:100466.
PMID: 38176467
Introduction: Cyberattacks represent a growing threat for healthcare delivery globally. We assess the impact and implications of a cyberattack on a cancer center in Ireland. Methods: On May 14th 2021...
5.
Rico Rios N, Bransfield A, Joyce C, Cahill M, OShaughnessy M, Costelloe S
Biochem Med (Zagreb)
. 2023 Dec;
34(1):011001.
PMID: 38125617
A case report of hemolysis in a female patient with Evans syndrome is described. The patient was admitted with anemia and jaundice and, during her 26-day hospital admission, had 83...
6.
Pallin N, OConnor M, Gannon A, Browne J, Cahill M, OShea D
Eur J Oncol Nurs
. 2023 Jul;
66:102378.
PMID: 37506608
Purpose: Supporting self-management is one strategy to help cancer survivors optimise their quality of life. Low grade non-Hodgkin's lymphoma is often incurable with a chronic disease trajectory requiring lifelong self-management....
7.
Kont A, Mendonca M, Cronin M, Cahill M, ODriscoll C
Int J Mol Sci
. 2022 Sep;
23(17).
PMID: 36077202
Non-viral delivery of therapeutic nucleic acids (NA), including siRNA, has potential in the treatment of diseases with high unmet clinical needs such as acute myeloid leukaemia (AML). While cationic biomaterials...
8.
Catherwood M, Wren D, Chiecchio L, Cavalieri D, Donaldson D, Lawless S, et al.
Front Oncol
. 2022 Jul;
12:909615.
PMID: 35837095
Limited data exists to show the correlation of (tumour protein 53) mutation detected by Next generation sequencing (NGS) and the presence/absence of deletions of 17p13 detected by FISH. The study...
9.
Scott C, Bartolovic K, Clark S, Waithe D, Hill Q, Okoli S, et al.
Br J Haematol
. 2022 Apr;
198(1):e10-e14.
PMID: 35417566
No abstract available.
10.
Benjamin D, ODonovan T, Laursen K, Orfali N, Cahill M, Mongan N, et al.
Front Oncol
. 2022 Mar;
12:848517.
PMID: 35280824
Acute myeloid leukemia (AML) is an aggressive blood cancer with an overall survival of 30%. One form of AML, acute promyelocytic leukemia (APL) has become more than 90% curable with...